Navigating the Complexities of Clinical Trial Budget Forecasting and Payments
Webinar Date/Time: Option 1: Thursday, February 1st, 2024 at 9am EST | 6am PST | 2pm GMT | 3pm CET Option 2: Thursday, February 1st, 2024 at 2pm EST | 11am PST | 7pm GMT | 8pm CET
Are you interested in learning about clinical trial forecasting and site payment best practices? Join IQVIA Technologies to learn how innovative technology can provide a comprehensive solution for managing finances in complex trials.
Register Free: https://www.appliedclinicaltrialsonline.com/act/forecasting-and-payments
Event overview
Join IQVIA Technologies for an informative webinar exploring the intricacies of clinical trial budget forecasting and payments. As trials continue to grow in complexity and scale, understanding budget forecasting best practices and site payment needs is crucial.
This presentation considers the complexities of conducting trials across multiple countries and sites, the increasing prevalence of protocol amendments, and the growing demand for timely payments. Don’t miss your chance to learn about strategies to manage trial payments, effective forecasting methods, and how technology can provide a comprehensive solution for managing trial finances.
Three key take-aways
In this webinar, you'll learn...
- Discuss the complexities of managing clinical trial budget forecasting and site payments and their impact on smooth trial operations.
- Gain insights into effective forecasting methods for clinical trial payments, highlighting the importance of real-time projections, technology, and consistent processes across studies.
- Explore the role of technology in managing trial finances and forecasting future spends.
Speakers:
Rajiv Prasad
Director, Financial Forecasting, Clinical Trial Payments
IQVIA Technologies
Rajiv Prasad has more than 25 years’ experience in information technology, product development, finance, strategy, and operations management. At IQVIA Technologies, Rajiv leads a team focused on automating and systematizing the forecasting of investigator grant activity and payments. Prior to IQVIA, he held technology leadership positions at Sutherland Global and Unisys, developing and implementing systems, products, and services portfolios. Rajiv holds a BE in Electrical Engineering from IIT Roorkee and a master’s degree in industrial engineering from IIM Bombay.
Jim DiCesare
Senior Director, Study Operations, Clinical Trial Payments
IQVIA Technologies
Jim DiCesare is passionate about delivering innovative Cost Benchmarking, CTA Negotiation and Site Payment services that support the clinical research conducted by sponsors and CROs. With over 25 years of industry experience leading clinical operations teams at Merck, DrugDev, and now IQVIA Technologies, Jim has expertise across the contracting, budgeting, and investigator grant payment management continuum. He is a frequent speaker at industry conferences and has written for a variety of publications. He has a B.S. in Accounting from Kutztown University.
Register Free: https://www.appliedclinicaltrialsonline.com/act/forecasting-and-payments
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Issues Complete Response Letter to Replimune for RP1 Combination Therapy in Advanced Melanoma
July 22nd 2025The FDA’s complete response letter cited concerns that the Phase I/II IGNYTE (NCT03767348) trial in advanced melanoma was not an adequate, well-controlled study and that its heterogeneous patient population limited interpretability, preventing approval in its current form.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
New FDA Initiative Reveals Common Reasons for Drug Application Rejection
July 11th 2025By publishing more than 200 complete response letters, the FDA is offering new visibility into the issues that most often delay drug approvals, including safety concerns, trial design flaws, and manufacturing gaps.
